Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1977 3
1978 2
1979 2
1980 2
1981 3
1982 3
1983 4
1984 4
1985 8
1986 4
1987 1
1988 6
1989 3
1990 1
1991 3
1992 6
1993 8
1994 5
1995 11
1996 4
1997 7
1998 9
1999 10
2000 13
2001 14
2002 5
2003 12
2004 18
2005 18
2006 13
2007 11
2008 31
2009 21
2010 29
2011 25
2012 20
2013 27
2014 22
2015 6
2016 11
2017 16
2018 10
2019 19
2020 20
2021 18
2022 18
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

484 results

Results by year

Filters applied: . Clear all
Page 1
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Vergote I, Perez Fidalgo A, Valabrega G, Monk BJ, Herzog T, Cibula D, Colombo N, Pothuri B, Sehouli J, Korach J, Barlin J, Papadimitriou CA, van Gorp T, Richardson D, McCarthy M, Antill Y, Mirza MR, Li K, Kalyanapu P, Slomovitz B, Coleman RL. Vergote I, et al. Among authors: papadimitriou ca. Int J Gynecol Cancer. 2024 Apr 16:ijgc-2024-005412. doi: 10.1136/ijgc-2024-005412. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38627035
Seismic assessment of bridges through structural health monitoring: a state-of-the-art review.
Karakostas C, Quaranta G, Chatzi E, Zülfikar AC, Çetindemir O, De Roeck G, Döhler M, Limongelli MP, Lombaert G, Apaydın NM, Pakrashi V, Papadimitriou C, Yeşilyurt A. Karakostas C, et al. Among authors: papadimitriou c. Bull Earthq Eng. 2024;22(3):1309-1357. doi: 10.1007/s10518-023-01819-3. Epub 2023 Nov 30. Bull Earthq Eng. 2024. PMID: 38419620 Free PMC article. Review.
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study.
Gwilym BL, Pallmann P, Waldron CA, Thomas-Jones E, Milosevic S, Brookes-Howell L, Harris D, Massey I, Burton J, Stewart P, Samuel K, Jones S, Cox D, Clothier A, Prout H, Edwards A, Twine CP, Bosanquet DC; Vascular and Endovascular Research Network (VERN) and the PERCEIVE study group. Gwilym BL, et al. BJS Open. 2024 Jan 3;8(1):zrad135. doi: 10.1093/bjsopen/zrad135. BJS Open. 2024. PMID: 38266124 Free PMC article.
A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.
Tabernero J, Yoshino T, Stintzing S, de Gramont A, Gibbs P, Jonker DJ, Nygren P, Papadimitriou C, Prager GW, Tell R, Lenz HJ. Tabernero J, et al. Among authors: papadimitriou c. Cancer Res Commun. 2024 Jan 4;4(1):28-37. doi: 10.1158/2767-9764.CRC-23-0361. Cancer Res Commun. 2024. PMID: 38059497 Free PMC article. Clinical Trial.
FLEXGRID - A novel smart grid architecture that facilitates high-RES penetration through innovative flexibility markets towards efficient stakeholder interaction.
Efthymiopoulos N, Makris P, Tsaousoglou G, Steriotis K, Vergados DJ, Khaksari A, Herre L, Lacort V, Martinez G, Lorente EL, Gehrcke R, Bagherpour M, Milzer G, Pellerin B, Farrukh F, Thoma M, Tadin T, Baka MI, Papadimitriou C, Kyprianou A, Georghiou GE, Pandzic H, Badanjak D, Chatzivasileiadis S, Prat E, Calin M, Esterl T, Pröstl Andrén F, Varvarigos E. Efthymiopoulos N, et al. Among authors: papadimitriou c. Open Res Eur. 2023 Oct 2;1:128. doi: 10.12688/openreseurope.14109.2. eCollection 2021. Open Res Eur. 2023. PMID: 37994356 Free PMC article.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: papadimitriou c. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis.
Tsantikidi A, Papazisis K, Floros T, Gazouli M, Papadopoulou E, Tsaousis G, Nasioulas G, Mester A, Milan KP, Gozman B, Afrasanie V, Stanculeanu DL, Trifanescu O, Pescaru F, Militaru C, Papadimitriou C. Tsantikidi A, et al. Among authors: papadimitriou c. Oncol Lett. 2023 Sep 22;26(5):480. doi: 10.3892/ol.2023.14060. eCollection 2023 Nov. Oncol Lett. 2023. PMID: 37809048 Free PMC article.
An impossibility theorem in game dynamics.
Milionis J, Papadimitriou C, Piliouras G, Spendlove K. Milionis J, et al. Among authors: papadimitriou c. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2305349120. doi: 10.1073/pnas.2305349120. Epub 2023 Oct 5. Proc Natl Acad Sci U S A. 2023. PMID: 37796988 Free PMC article.
484 results